Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HRTX | Common Stock | Other | $5.41K | +1.65K | +7.99% | $3.27 | 22.3K | Oct 31, 2022 | Direct | F1 |
transaction | HRTX | Common Stock | Options Exercise | +1.25K | +5.59% | 23.6K | Jan 13, 2023 | Direct | F2 | ||
transaction | HRTX | Common Stock | Options Exercise | +4.56K | +19.34% | 28.2K | Jan 13, 2023 | Direct | F2 | ||
transaction | HRTX | Common Stock | Tax liability | -$6.38K | -2.01K | -7.14% | $3.17 | 26.2K | Jan 13, 2023 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HRTX | Restricted Stock Units | Options Exercise | $0 | -1.25K | -12.5% | $0.00 | 8.75K | Jan 13, 2023 | Common Stock | 1.25K | Direct | F2, F4 | |
transaction | HRTX | Restricted Stock Units | Options Exercise | $0 | -4.56K | -12.31% | $0.00 | 32.5K | Jan 13, 2023 | Common Stock | 4.56K | Direct | F2, F5 |
Id | Content |
---|---|
F1 | Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2022. |
F2 | Restricted stock units convert into common stock on a one-for-one basis. |
F3 | Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
F4 | The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). |
F5 | The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). |